DERM
Journey Medical Corp
6.10$
-2.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 59.2% | 97.9% | 90.8% | 99.3% | 97.4% | 74.6% | 67.9% | 86.9% | 73.9% | 73.5% | 60.0% | 70.7% | |
| 31.1% | 48.3% | 13.4% | 52.8% | 30.5% | 14.2% | 15.9% | 50.5% | 30.4% | 35.7% | 25.3% | 25.5% | |
| 54.5% | 96.7% | 80.6% | 98.3% | 90.9% | 14.2% | 15.9% | 50.5% | 30.4% | 35.7% | 25.3% | 25.5% | |
| 4.1% | – | 6.8% | 0.0% | 1.7% | 56.0% | 46.1% | 23.8% | 26.8% | 19.8% | 12.8% | 31.5% | |
| – | – | – | – | 2.4% | 2.5% | 2.7% | 10.1% | 13.5% | 13.3% | 18.0% | 10.2% | |
| – | – | – | – | – | 0.3% | 0.3% | 0.1% | 0.2% | – | – | – | |
| 0.4% | 0.3% | 0.2% | 0.1% | 0.2% | – | – | – | – | – | – | – | |
| 2.0% | 0.5% | 0.4% | 0.2% | 0.3% | 21.8% | 29.0% | 12.9% | 25.9% | 26.4% | 39.7% | 29.2% | |
| 13.8% | 16.4% | 20.9% | 73.3% | 102.6% | 91.9% | 80.2% | 56.8% | 83.9% | 73.5% | 75.0% | 66.3% | |
| 6.7% | 11.7% | 11.2% | 18.8% | 11.2% | 61.7% | 54.1% | 53.0% | 63.6% | 54.5% | 43.8% | 39.6% | |
| 0.4% | 0.5% | 1.0% | 0.8% | – | 0.2% | 8.9% | 5.6% | 2.9% | 4.0% | 0.9% | 0.1% | |
| 3.1% | 4.2% | 4.3% | 2.7% | 4.6% | 6.2% | 3.8% | 23.4% | 35.2% | 20.9% | 20.0% | 9.8% | |
| – | – | – | – | – | 15.4% | 10.1% | – | 18.9% | 19.0% | 31.0% | 26.7% | |
| 86.2% | 83.6% | 79.1% | 26.7% | -2.6% | 8.1% | 19.8% | 43.2% | 16.1% | 26.5% | 25.0% | 33.7% | |
| -46.4% | -72.6% | -80.0% | -98.7% | -216.4% | -0.5% | 9.9% | -40.0% | -65.1% | -94.2% | -108.5% | -104.1% | |
| 13.8% | 12.0% | 10.6% | 7.2% | 12.2% | 49.2% | 32.1% | 17.8% | 16.7% | 23.7% | 25.5% | 25.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.